more_reports

BeyondSpring Pharmaceuticals Inc.

BYSI:NASDAQ

BeyondSpring is a global clinical stage biopharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from collaboration with University of Washington in de novo drug discovery using ubiquitination platform.

streetwise book logo Streetwise Company Fact Sheet

2024/11/8 9:47:53

(BYSI:NASDAQ)